Monitoring levels of DNA in the blood could indicate treatment response

Monitoring levels of DNA in the blood could indicate treatment response

Monitoring levels of DNA shed by tumors and circulating in the bloodstream could help doctors accurately assess how gastroesophageal cancers are responding to treatment, and potentially predict future prognosis, suggests a new study led by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

 READ HERE
SEE ALL NEWS
Recent Posts
Personalized Vaccine for Liver Cancer Shows Promise in Clinical Trial Immunotherapy Combination May Benefit Patients with Transplanted Kidneys and Advanced Skin Cancers Colorectal Cancer Gene Implicated in Broad Range of Solid Tumors Johns Hopkins Investigators Develop Novel Treatment for T-cell Leukemias and Lymphomas Robotic surgeon precisely removes cancerous tumors Podcast: Pancreatitis and Pancreatic Cancer Age-Related Changes in Fibroblast Cells Promote Pancreatic Cancer Growth and Spread Amount Of Repetitive DNA In Blood Hints at Cancer Early Podcast: Colorectal Cancer